our expertise
Pancreatic cancer and new therapeutic scenarios
Organization of a media tutorial on “Pancreatic cancer in advanced stages: clinical needs and new therapeutic scenarios”, featuring top oncology experts to support the Italian launch of pegylated liposomal irinotecan Nal-IRI—the first approved second-line treatment for pancreatic cancer.
Managed press office activities including contents, press release distribution, and media monitoring.
